Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifevantage (LFVN) EBIT (2016 - 2025)

Lifevantage's EBIT history spans 16 years, with the latest figure at $487000.0 for Q4 2025.

  • For Q4 2025, EBIT fell 85.79% year-over-year to $487000.0; the TTM value through Dec 2025 reached $9.0 million, down 17.4%, while the annual FY2025 figure was $12.2 million, 181.6% up from the prior year.
  • EBIT reached $487000.0 in Q4 2025 per LFVN's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $6.6 million in Q2 2021 to a low of -$1.3 million in Q4 2023.
  • Average EBIT over 5 years is $2.0 million, with a median of $2.0 million recorded in 2021.
  • Peak YoY movement for EBIT: tumbled 244.13% in 2022, then soared 371.85% in 2024.
  • A 5-year view of EBIT shows it stood at -$358000.0 in 2021, then crashed by 244.13% to -$1.2 million in 2022, then fell by 2.35% to -$1.3 million in 2023, then skyrocketed by 371.85% to $3.4 million in 2024, then plummeted by 85.79% to $487000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFVN's EBIT are $487000.0 (Q4 2025), $2.3 million (Q3 2025), and $2.1 million (Q2 2025).